Transarterial chemoembolization (TACE) was introduced in 1977 with the administration of
chemotherapeutic agent to gelatin sponge particles through the hepatic artery in patients …

Transcatheter arterial therapies for hepatocellular carcinoma (HCC) have developed during
the last decade. A fine powder formulation of cisplatin and the new platinum agent miriplatin …

Ultraselective conventional transarterial chemoembolization (cTACE), defined as cTACE at
the most distal portion of the subsubsegmental hepatic artery, is mainly performed for …

Transarterial chemoembolization (TACE) is a first-line treatment for patients with
hepatocellular carcinoma (HCC) in Barcelona Clinic Liver Cancer stage B (BCLC-B). There …

Conventional transarterial chemoembolization with ethiodized oil and gelatin sponge (GS)
particles is a standard technique for hepatocellular carcinoma. Ethiodized oil can …

Background: This study aimed to compare the therapeutic effectiveness including
progression-free survival (PFS), overall survival (OS), and safety of conventional …

The rabbit VX2 is a large animal model of cancer used for decades by interventional
radiologists to demonstrate the efficacy of various locoregional treatments against liver …

Purpose To investigate material density, flow, and viscosity effects on microsphere
distribution within an in vitro model designed to simulate hepatic arteries. Materials and …

Rationale and Objectives This study aimed to propose a novel approach of lipiodol
combined with drug-eluting beads transarterial chemoembolization (Lipiodol-DEB TACE) …

Aim To investigate the change of tumor feeding artery diameter and the efficacy of
metastasis inhibition after transarterial chemoembolization (TACE) combined with apatinib …